A detailed history of Perkins Capital Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 93,930 shares of VCYT stock, worth $3.72 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares
93,930
Previous 98,830 4.96%
Holding current value
$3.72 Million
Previous $2.14 Million 49.28%
% of portfolio
3.14%
Previous 2.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$21.0 - $35.25 $102,900 - $172,725
-4,900 Reduced 4.96%
93,930 $3.2 Million
Q2 2024

Aug 09, 2024

SELL
$18.86 - $23.55 $323,449 - $403,882
-17,150 Reduced 14.79%
98,830 $2.14 Million
Q1 2024

May 09, 2024

SELL
$21.0 - $29.1 $25,200 - $34,920
-1,200 Reduced 1.02%
115,980 $2.57 Million
Q4 2023

Jan 22, 2024

SELL
$19.72 - $28.68 $49,300 - $71,700
-2,500 Reduced 2.09%
117,180 $3.22 Million
Q3 2023

Nov 02, 2023

SELL
$22.33 - $29.92 $36,844 - $49,368
-1,650 Reduced 1.36%
119,680 $2.67 Million
Q2 2023

Jul 21, 2023

SELL
$20.96 - $26.99 $11,528 - $14,844
-550 Reduced 0.45%
121,330 $3.09 Million
Q1 2023

May 09, 2023

SELL
$20.58 - $27.89 $23,666 - $32,073
-1,150 Reduced 0.93%
121,880 $2.72 Million
Q4 2022

Jan 26, 2023

SELL
$15.31 - $29.94 $7,655 - $14,970
-500 Reduced 0.4%
123,030 $2.92 Million
Q3 2022

Oct 24, 2022

SELL
$16.58 - $27.9 $76,267 - $128,340
-4,600 Reduced 3.59%
123,530 $2.05 Million
Q2 2022

Jul 29, 2022

BUY
$15.45 - $29.52 $79,567 - $152,028
5,150 Added 4.19%
128,130 $2.55 Million
Q1 2022

Apr 20, 2022

SELL
$21.94 - $42.51 $16,455 - $31,882
-750 Reduced 0.61%
122,980 $3.39 Million
Q4 2021

Feb 10, 2022

SELL
$36.09 - $53.79 $45,112 - $67,237
-1,250 Reduced 1.0%
123,730 $5.1 Million
Q2 2021

Jul 28, 2021

SELL
$32.94 - $56.62 $49,410 - $84,930
-1,500 Reduced 1.19%
124,980 $5 Million
Q1 2021

Apr 28, 2021

SELL
$44.47 - $81.38 $26,682 - $48,828
-600 Reduced 0.47%
126,480 $6.8 Million
Q4 2020

Feb 09, 2021

SELL
$32.49 - $61.88 $113,715 - $216,580
-3,500 Reduced 2.68%
127,080 $6.22 Million
Q3 2020

Oct 28, 2020

BUY
$26.73 - $35.67 $236,560 - $315,679
8,850 Added 7.27%
130,580 $4.24 Million
Q1 2020

Apr 29, 2020

SELL
$16.13 - $30.17 $175,817 - $328,853
-10,900 Reduced 8.22%
121,730 $2.96 Million
Q4 2019

Feb 03, 2020

SELL
$20.78 - $29.99 $322,090 - $464,845
-15,500 Reduced 10.46%
132,630 $3.7 Million
Q3 2019

Oct 23, 2019

SELL
$23.87 - $30.93 $507,237 - $657,262
-21,250 Reduced 12.55%
148,130 $3.56 Million
Q2 2019

Aug 09, 2019

SELL
$22.1 - $28.56 $620,126 - $801,393
-28,060 Reduced 14.21%
169,380 $4.83 Million
Q1 2019

Apr 22, 2019

SELL
$12.0 - $25.76 $135,180 - $290,186
-11,265 Reduced 5.4%
197,440 $4.94 Million
Q4 2018

Feb 11, 2019

SELL
$9.15 - $14.85 $26,077 - $42,322
-2,850 Reduced 1.35%
208,705 $2.63 Million
Q3 2018

Oct 22, 2018

BUY
$9.55 - $12.64 $579,685 - $767,248
60,700 Added 40.24%
211,555 $2.02 Million
Q2 2018

Aug 02, 2018

BUY
$5.39 - $9.66 $708,650 - $1.27 Million
131,475 Added 678.41%
150,855 $1.41 Million
Q1 2018

Apr 23, 2018

BUY
$5.44 - $6.97 $105,427 - $135,078
19,380 New
19,380 $108,000
Q4 2017

Jan 26, 2018

SELL
$6.05 - $9.37 $376,763 - $583,516
-62,275 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$7.81 - $8.77 $486,367 - $546,151
62,275
62,275 $546,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.83B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.